Posted 7/21/2017 10:18 PM (GMT 0)
Hello,
On Wednesday I had surgery but on Monday I had a MRI and just got the results. It's all Greek to me! If someone can distill it down to layman's terms I'd greatly appreciate it. The surgeon, who has done 4000 RPs said it all went well and he felt a firmness on the left side of the prostate. Path lab results come next week. Here is what I was sent:
MRI PROSTATE WWO; 7/17/2017 4:02 PM
CLINICAL INFORMATION: Male 63 years old Reason: staging History: clinical trial exam,
prostate biopsy 5/9/2017
TECHNIQUE: Multiplanar, multisequence MRI of the prostate. Pre and post contrast sequences
were obtained following intravenous administration of 17mL Multihance (Per Tech Bruce via
phone);
COMPARISON: None
FINDINGS:
PELVIS:
PROSTATE:
Prostate Size: 5.2 x 4.1 x 4.7 cm.
Peripheral Zone: Heterogeneous. Low T2 signal lesion with areas of restricted diffusion
in the left mid gland to apex peripheral zone measures at least 7 mm
Central Gland: T2 hyperintense lesion in the lower anterior gland which appears globular
and has some areas of low ADC measures 10 mm
Multiple nodules in the central gland with areas of restricted diffusion heterogeneity
likely representing BPH nodules. This causes asymmetric hypertrophy of the left central
gland distortion of the gland architecture.
Seminal Vesicles: Seminal vessels are not distended.
Extracapsular Extension: No definite
BLADDER: No significant abnormality noted.
LYMPH NODES: No pelvic lymphadenopathy.
BONES, SOFT TISSUES: No significant abnormality noted.
OTHER: No significant abnormality noted.
IMPRESSION:
1. Left peripheral zone 7 mm lesion - PIRADS 5
2. Apical anterior lesion - PIRADS 4
PI-RADS v2 Assessment Categories:
PIRADS 1 - Very low (clinically significant cancer is highly unlikely to be present)
PIRADS 2 - Low (clinically significant cancer is unlikely to be present)
PIRADS 3 - Intermediate (the presence of clinically significant cancer is equivocal)
PIRADS 4 - High (clinically significant cancer is likely to be present)
PIRADS 5 - Very high (clinically significant cancer is highly likely to be present)
https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2
pdf
Report Electronically Signed: 7/18/2017 10:25 AM